Origin Asset Management LLP Boosts Stake in Aetna Inc. (AET)
Origin Asset Management LLP lifted its position in shares of Aetna Inc. (NYSE:AET) by 23.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 197,233 shares of the company’s stock after acquiring an additional 38,000 shares during the quarter. Aetna makes up 1.8% of Origin Asset Management LLP’s investment portfolio, making the stock its 18th largest position. Origin Asset Management LLP owned approximately 0.06% of Aetna worth $29,946,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of AET. Signature Estate & Investment Advisors LLC bought a new position in shares of Aetna during the 1st quarter worth $133,000. MUFG Securities EMEA plc bought a new position in shares of Aetna during the 1st quarter worth $25,510,000. First Trust Advisors LP grew its stake in shares of Aetna by 18.5% during the 1st quarter. First Trust Advisors LP now owns 210,444 shares of the company’s stock worth $26,842,000 after acquiring an additional 32,785 shares during the period. Diamond Hill Capital Management Inc. grew its stake in shares of Aetna by 7.0% during the 1st quarter. Diamond Hill Capital Management Inc. now owns 1,656,372 shares of the company’s stock worth $211,270,000 after acquiring an additional 108,874 shares during the period. Finally, FTB Advisors Inc. grew its stake in shares of Aetna by 11.0% during the 1st quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock worth $125,000 after acquiring an additional 97 shares during the period. Institutional investors own 89.58% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Origin Asset Management LLP Boosts Stake in Aetna Inc. (AET)” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at https://www.thecerbatgem.com/2017/09/13/origin-asset-management-llp-boosts-stake-in-aetna-inc-aet.html.
Shares of Aetna Inc. (NYSE:AET) traded down 0.13% during mid-day trading on Wednesday, hitting $162.62. The stock had a trading volume of 455,514 shares. The company has a market cap of $54.01 billion, a PE ratio of 36.10 and a beta of 0.53. The stock’s 50-day moving average is $156.47 and its 200 day moving average is $144.33. Aetna Inc. has a 12 month low of $104.59 and a 12 month high of $164.30.
Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, topping analysts’ consensus estimates of $2.34 by $1.08. The firm had revenue of $15.52 billion during the quarter, compared to analyst estimates of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The business’s quarterly revenue was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.21 earnings per share. On average, equities research analysts forecast that Aetna Inc. will post $9.55 earnings per share for the current fiscal year.
Several research analysts have recently weighed in on AET shares. Stifel Nicolaus increased their price target on Aetna from $150.00 to $158.00 and gave the stock a “buy” rating in a research note on Tuesday, May 16th. Royal Bank Of Canada increased their price target on Aetna from $147.00 to $162.00 and gave the stock an “outperform” rating in a research note on Friday, June 9th. BidaskClub downgraded Aetna from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Deutsche Bank AG increased their price target on Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research note on Monday, August 7th. Finally, UBS AG reiterated a “buy” rating and set a $160.00 price target (up previously from $147.00) on shares of Aetna in a research note on Wednesday, May 17th. Seven research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $159.04.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.